Search clinical trials for: multifactorial treatment

Total 63095 results

National Taiwan University Hospital

Unknown

Appendicitis With Medical Treatment

Appendicitis

Taiwan
Vanderbilt University

Completed

Olanzapine Versus Clozapine in Treatment Refractory Schizophrenia

Schizophrenia | Schizoaffective Disorder
Biogen

Completed

Treatment of Relapsed Low-Grade or Follicular Lymphoma With Rituximab (Also Known as Rituxan, IDEC-C2B8, IDEC-102)

Low-Grade or Follicular B-Cell Non-Hodgkin's Lymphoma

United States, Canada
University of Pittsburgh

Completed

Evaluation of Alternative Exercise Treatments on Weight Loss in Overweight Women.

Obesity | Weight Loss

United States
Bayside Health
National Health and Medical Research Council, Australia; Monash University; Cystic...

Unknown

Treatment of Metabolic Alkalosis in Acute Exacerbations of Cystic Fibrosis

Cystic Fibrosis

Australia
Centers for Disease Control and Prevention
University of Washington

Completed

Intervening With Children/Adolescents With FAS/ARND

Treatment | Control

United States
Caroff, Stanley N., M.D.
Ortho-McNeil Neurologics, Inc.

Completed

Treatment of Tardive Dyskinesia With Galantamine

Tardive Dyskinesia

United States
Bassett Healthcare
PriCara, Unit of Ortho-McNeil, Inc.

Completed

Comparative Effects of Azithromycin, Telithromycin and Levofloxacin on Drug Metabolizing Enzymes

Healthy
Chinese University of Hong Kong

Completed

Multi-Center Prospective Randomized Trial Comparing Standard Esophagectomy Against Chemo-Radiotherapy for Treatment of Squamous Esophageal Cancer - Early Results From the Chinese University Research Group for Esophageal Cancer (CURE)

Esophageal Cancer

China
University of Sydney

Completed

Intravitreal Triamcinolone for Clinically Significant Diabetic Macular Oedema That Persists After Laser Treatment (TDMO)

Diabetic Macular Oedema

Australia
Centers for Disease Control and Prevention
US Department of Veterans Affairs

Completed

TBTC Study 25: Study of the Tolerability of Higher Doses of Rifapentine in the Treatment of Tuberculosis

Tuberculosis

United States, Canada
Technische Universität Dresden

Completed

Psychiatric Day Hospital Treatment

Personality Disorders | Schizophrenia | Anxiety Disorders | Adjustment Disorders | Depressive Disorders

Czech Republic, Germany, Poland, Slovakia, United Kingdom
National Taiwan University Hospital
National Health Research Institutes, Taiwan

Unknown

Immunotherapy for Colorectal Cancers Using CEA-Pulsed Dendritic Cells and Subsequent IL-2 Treatment

Colorectal Cancer

Taiwan
National Taiwan University Hospital

Unknown

Progestin Treatment for Endometrial Stromal Cells in Adenomyosis

Endometriosis

Taiwan
National Taiwan University Hospital

Unknown

Topical 5-ALA Photodynamic Therapy for the Treatment of Verruca Vulgaris

Warts

Taiwan
Ludwig-Maximilians - University of Munich
Heinrich-Heine University, Duesseldorf; University of Cologne; RWTH Aachen University and other collaborators

Unknown

Optimization of Acute Treatment in First Episode Schizophrenia

Schizophrenia, First-Episode

Germany
Toronto Rehabilitation Institute
Ontario Neurotrauma Foundation

Completed

Effectiveness of Vibration and Standing Versus Standing Alone for the Treatment of Osteoporosis for People With Spinal Cord Injury.

Spinal Cord Injury. | Osteoporosis.

Canada
Centers for Disease Control and Prevention
Kenya Medical Research Institute

Completed

In-Vivo Response of P. Falciparum to Antimalarial Treatment in HIV-Infected and HIV-Uninfected Adults

HIV | Malaria | AIDS

Kenya
UMC Utrecht

Completed

Study on Chronic Hepatitis C Treatment With Interferon Alpha, Ribavirin and Amantadine in Naive Patients

Chronic Hepatitis C

Netherlands
Centers for Disease Control and Prevention
US Department of Veterans Affairs

Completed

TBTC Study 22: Efficacy of Once-Weekly Rifapentine and Isoniazid in Treatment of Tuberculosis

Pulmonary Tuberculosis

United States, Canada
Hospital de Sabadell
Bristol-Myers Squibb

Unknown

Multifactorial Intervention on Cardiovascular Risk Factors in Subjects With Peripheral Arterial Disease

Smoking | Hypertension | Diabetes Mellitus | Peripheral Arterial Disease | Hypercholesterolemia

Spain
Centers for Disease Control and Prevention
US Department of Veterans Affairs

Completed

TBTC Study 23: Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen

HIV Infections | Tuberculosis

United States, Canada
Mylan Bertek Pharmaceuticals

Completed

Long Term Safety and Efficacy of SC Apomorphine in Treatment of "Off" Episodes in Late-Stage Parkinson's Disease

Parkinson Disease

United States
Lymphoma Study Association

Completed

Randomized Study for Patients With Follicular Lymphoma Needing Treatment

Follicular Lymphoma

France, Belgium
Rafa Laboratories
Dr. Falk Pharma GmbH

Completed

Treatment of Gastro-Intestinal and/or Hepatic Graft Versus Host Disease With Budesonide in Patients Following Peripheral Blood Stem Cell Transplantation

Graft Vs Host Disease

Israel
University Hospital, Saarland
Hoffmann-La Roche

Unknown

Peginterferon Alfa-2a, Ribavirin, Amantadine/Placebo in Hepatitis C Virus (HCV)-Genotype-1-Infection (PRAMA)

Hepatitis C, Chronic
Centers for Disease Control and Prevention
University of Alabama at Birmingham; Universidad del Valle, Guatemala

Completed

Clinical Trial of Rifampin and Azithromycin for the Treatment of River Blindness

Onchocerciasis

Guatemala
Centers for Disease Control and Prevention
Ministry of Health and Population, Malawi

Completed

Prevention of Malaria During Pregnancy Using Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine: Malawi

HIV Infections | Malaria, Falciparum

Malawi
CollaGenex Pharmaceuticals

Completed

A Clinical Trial to Determine the Effects of 40 Mg Doxycycline Versus a Placebo Control for the Treatment of Rosacea

Rosacea
East Valley Hematology and Oncology Medical Group
Astex Pharmaceuticals, Inc.; Pharmatech Oncology; Mena, Raul, M.D.

Unknown

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Chronic Lymphocytic Leukemia

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Detoxification - BBDVI - 19

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Detoxification With Two Types of Treatment. BBD IV - 13

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Pharmacology Related to Addiction Treatment - 18

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Pharmacology Related to Addiction Treatment - 21

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate Day Buprenorphine Administration, Phase X - 15

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate Day Buprenorphine Administration, Phase XII - 17

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Detox With Two Types of Treatment. BBD I - 10

Opioid-Related Disorders

United States
Profess Medical Consultancy

Completed

Study With Migraid Device in Acute, Early Treatment of Migraine With Typical Aura

Migraine With Typical Aura

Netherlands
French National Agency for Research on AIDS and...
Schering-Plough

Terminated

Structured Treatment Interruptions With or Without Pegylated Interferon Alpha for HIV-Infected Patients After Prolonged Viral Suppression

HIV Infections

France
Universitätsklinikum Hamburg-Eppendorf

Completed

Metyrapone as Additive Treatment in Major Depression

Major Depressive Disorder

Germany
Makerere University
Ministry of Health, Uganda; Sanofi-Synthelabo

Unknown

Efficacy of Intrarectal Versus Intravenous Quinine for the Treatment of Childhood Cerebral Malaria

Cerebral Malaria

Uganda
French National Agency for Research on AIDS and...
Bristol-Myers Squibb; Gilead Sciences

Terminated

Efficacy and Safety of Tenofovir DF/Atazanavir Enhanced With Low Dose of Ritonavir in HIV-Infected Patients

HIV Infections

France
Connor, Kathryn M., M.D.
Forest Laboratories

Completed

Study of Escitalopram in the Treatment of Specific Phobia

Phobic Disorders

United States
Pharmasset

Completed

A 14-Day Study of Racivir When Used in Combination in HIV-Infected Males

HIV Infections
Otsuka America Pharmaceutical

Completed

Safety and Efficacy of Pletal (Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's Phenomenon

Raynaud's Disease

United States
Otsuka America Pharmaceutical

Completed

Safety and Efficacy of Pletal(Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's Phenomenon

Raynaud's Disease

United States
University of Sydney
National Health and Medical Research Council, Australia; Sydney South West... and other collaborators

Unknown

Trial for the Treatment of Alcohol Dependence

Alcoholism

Australia
National Center for Research Resources (NCRR)
National Multiple Sclerosis Society

Completed

Antibiotic Treatment Trial Directed Against Chlamydia Pneumonia in Multiple Sclerosis

Multiple Sclerosis

United States
Palo Alto Medical Foundation

Completed

Toxoplasmic Encephalitis in Patients With AIDS. Treatment and Prevention of Relapse

HIV Infections | Toxoplasmosis, Cerebral

United States
Glaxo Wellcome

Completed

A Study of Zidovudine and T Lymphocyte Transfer in the Treatment of HIV Type III in Patients With AIDS

HIV Infections

United States

Search clinical trials for: multifactorial treatment

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Costa Rica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations